This company seems to have been delisted
Reason: Rebranded as GeneDx
Last recorded trade on: March 14, 2023
Source: https://ir.genedx.com/news-releases/news-release-details/sema4-announces-name-change-genedx-and-provides-preliminary-2022
Reason: Rebranded as GeneDx
Last recorded trade on: March 14, 2023
Source: https://ir.genedx.com/news-releases/news-release-details/sema4-announces-name-change-genedx-and-provides-preliminary-2022
Sema4
SMFR
₹27.00
Share price
26.78%
Change (1 day)
-86.98%
Change (1 year)
Categories
Sema4 (SMFR) - P/B ratio
P/B ratio as of March 2025 : 0.2140
According to Sema4's latest financial reports the company has a price-to-book ratio of 0.519754.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Sema4 - P/B ratio (from 2021 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 0.1818 | -93.44% |
| 2021-12-31 | 2.77 | |
| 2020-12-31 | N/A |